MMV055 Dose 2 clinical trials

Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combination With MMV371 in Healthy Participants

This study is testing a new medicine, MMV055, for malaria in healthy volunteers. It will check how safe it is, any side effects, and how it moves through the body, both on its own and with another medicine, MMV371. The goal is to see if it could be a future malaria treatment.